Bayer CropScience
Ticker > Company >

Bayer CropScience share price

Bayer CropScience Ltd.

NSE: BAYERCROP BSE: 506285 SECTOR: Pesticides & Agrochemicals  106k   408   28

5055.50
-56.30 (-1.10%)
NSE: Today, 01:34 PM

Price Summary

Today's High

₹ 5142.85

Today's Low

₹ 5040.05

52 Week High

₹ 7196.85

52 Week Low

₹ 4784.85

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 22720.47 Cr.

Enterprise Value

₹ 21556.47 Cr.

No. of Shares

4.49 Cr.

P/E

39.2

P/B

7.37

Face Value

₹ 10

Div. Yield

2.76 %

Book Value (TTM)

₹  685.83

CASH

₹ 1164 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

71.43 %

EPS (TTM)

₹  128.97

Sales Growth

-0.71%

ROE

26.63 %

ROCE

34.56%

Profit Growth

-2.33 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Bayer CropScience Ltd.

Confidor Bolfo Bi-Larv Bayrocin Baymix Adora Bay.o.Pet Decis Drontal Euglim Exel-Aqua Incid Monceren Movento ProAgro Raxil Solfac Vagestam Xirtam

Index Presence

The company is present in 19 Indices.

NMID150Q50

NIFTY Midcap150 Quality 50
23118.1
  289.349999999999 (1.26748069868039%)

NIFTY500

Nifty 500
21835.25
  107.799999999999 (0.496146579557188%)

NIFTYMIDCAP150

Nifty Midcap 150
20051.5
  202.349999999999 (1.01943911955926%)

NIFTYMIDSMALL400

Nifty MidSmallcap 400
18653.9
  229.850000000002 (1.24755414797508%)

NIF500LGMIDSML

Nifty500 LargeMidSmall Equal-Cap Weighted Index
16708.85
  155.799999999999 (0.941216271321599%)

NIFTYLGEMID250

NIFTY LargeMidcap 250
15255.55
  91.5999999999985 (0.604064244474545%)

NY500MUL50:25:25

Nifty500 Multicap 50:25:25
15171.35
  113.15 (0.751417832144607%)

NFT500EQUAL

Nifty 500 Equal Weight
13361.9
  139.199999999999 (1.05273506923698%)

NIFTYTOTALMCAP

NIFTY Total Market
12301.95
  65.4000000000015 (0.534464371084997%)

MIDCAP

Bse MidCap
43490.04
  414.82 (0.963013073409713%)

BSE500

Bse 500
34335.06
  137.489999999998 (0.402046110293797%)

MID150

Bse 150 MidCap Index
15061.46
  146.169999999998 (0.980001059315638%)

MSL400

Bse 400 MidSmallCap Index
11346.67
  128.4 (1.14456150547277%)

LMI250

Bse 250 LargeMidCap Index
10206.93
  29.6399999999994 (0.291236665163308%)

COMDTY

BSE Commodities
7144.61
  78.7999999999993 (1.11522953490115%)

SPBSQIP

Bse Quality Index
1733.76
  1.58999999999992 (0.091792376036981%)

ALLCAP

Bse Allcap
10471.31
  71.0699999999997 (0.683349615008888%)

S&P LARGEMIDCAP

Bse LargeMidCap
10071.69
  156.290000000001 (1.5762349476572%)

S&P MIDSMLCAP

Bse MidSmallCap
12400.6
  155.5 (1.2698957133874%)

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-0.71%
3 Year6.19%
5 Year10.01%

Profit Growth

1 Year-2.33%
3 Year14.52%
5 Year17.05%

ROE%

1 Year26.63%
3 Year27.01%
5 Year24.01%

ROCE %

1 Year34.56%
3 Year35.7%
5 Year32.68%

Debt/Equity

0

Price to Cash Flow

23.88

Interest Cover Ratio

49.0306

CFO/PAT (5 Yr. Avg.)

1.00559197840339

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2024 71.43 0.00
Sep 2024 71.43 0.00
Jun 2024 71.43 0.00
Mar 2024 71.43 0.00
Dec 2023 71.43 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 27.0069488025329% over the past 3 years.
  • Company has been maintaining healthy ROCE of 35.7030911651493% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 49.0306.
  • The company has an efficient Cash Conversion Cycle of 60.2764 days.
  • Company has a healthy liquidity position with current ratio of 2.2717.
  • The company has a good cash flow management; CFO/PAT stands at 1.00559197840339.
  • The company has a high promoter holding of 71.43%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.27017787407522.

 Limitations

  • The company has shown a poor revenue growth of 6.19398020605406% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 1617.2 954.9 791.5 1631.2 1737.6
Total Expenditure 1312.3 827 694.9 1317.2 1553.8
Operating Profit 304.9 127.9 96.6 314 183.8
Other Income 16.1 14.6 29.6 27.5 23.7
Interest 3.7 3.1 4.9 4.2 3.4
Depreciation 11.6 15.2 15.9 21.5 14
Exceptional Items 0 0 0 0 0
Profit Before Tax 305.7 124.2 105.4 315.8 190.1
Tax 82.8 31.1 9.4 61.6 53.8
Profit After Tax 222.9 93.1 96 254.2 136.3
Adjusted EPS (Rs) 49.64 20.74 21.38 56.61 30.36

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 3609.4 4261.3 4734.4 5139.7 5103.2
Total Expenditure 2883.7 3451.7 3928.6 4224.5 4152.4
Operating Profit 725.7 809.6 805.8 915.2 950.8
Other Income 66.7 65.9 59.9 72.9 84.2
Interest 13.8 12.6 12.9 22.3 19.6
Depreciation 65.3 73.5 64.5 79.5 74
Exceptional Items -130.2 5.1 58.5 103.8 0
Profit Before Tax 583.1 794.5 846.8 990.1 941.4
Tax 108.6 301.4 201.5 231.9 200.9
Net Profit 474.5 493.1 645.3 758.2 740.5
Adjusted EPS (Rs.) 105.68 109.82 143.72 168.86 164.92

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 44.9 44.9 44.9 44.9 44.9
Total Reserves 2527.6 2505.4 2479.4 2667.2 2804.5
Borrowings 0 0 0 0 0
Other N/C liabilities 1590.2 1783.1 2364.5 2792.4 2951.9
Current liabilities 1765.1 2273.2 2072.9 1995.1 1815
Total Liabilities 5927.8 6606.6 6961.7 7499.6 7616.3
Assets
Net Block 438 394.7 441.4 436.8 389.4
Capital WIP 3.6 7.6 13.3 2.9 6.4
Intangible WIP 52.3 68.7 85 106.3 112.2
Investments 0 0 0 0 0
Loans & Advances 1762.9 1858.8 2406.3 2813.6 2959.7
Other N/C Assets 30.9 30.3 26.6 26 25.5
Current Assets 3640.1 4246.5 3989.1 4114 4123.1
Total Assets 5927.8 6606.6 6961.7 7499.6 7616.3
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 583.1 794.5 846.8 990.1 941.4
Adjustment 190.6 62.1 39.1 -0.4 108.4
Changes in Assets & Liabilities 28.1 -7.4 -406.2 -140.9 33.9
Tax Paid -135.9 -162.5 -264.2 -239.5 -132.1
Operating Cash Flow 665.9 686.7 215.5 609.3 951.6
Investing Cash Flow -28.9 6.7 64.2 83.3 0.4
Financing Cash Flow -148.3 -555.8 -703.3 -613.2 -656.3
Net Cash Flow 488.7 137.6 -423.6 79.4 295.7

Corporate Actions

Investors Details

PARTICULARS Dec 2023% Mar 2024% Jun 2024% Sep 2024% Dec 2024%
promoters 71.43 71.43 71.43 71.43 71.43
bayer ag 8.43 8.43 8.43 8.43 8.43
bayer cropscience ag 11.91 11.91 11.91 11.91 11.91
bayer investments india p... - - 15.04 15.04 15.04
bayer sas 14.73 14.73 14.73 14.73 14.73
bayer vapi private limite... - 17.89 17.89 17.89 17.89
monsanto company 3.44 3.44 3.44 3.44 3.44
monsanto investments indi... 15.04 15.04 - - -
bayer vapi pivate limited... 17.89 - - - -
PARTICULARS Dec 2023% Mar 2024% Jun 2024% Sep 2024% Dec 2024%
investors 28.57 28.57 28.57 28.57 28.57
aditya birla sun life tru... - 2.28 2.33 2.33 2.15
indian syntans investment... 1.04 1.04 1.04 1.04 1.04
investor education and pr... 0.27 - - - 0.28
llp 0.01 0.01 0.03 0.03 0.03
nippon life india trustee... 1.97 1.97 2.09 2.10 2.16
quant mutual fund - quant... - - - 1.78 2.32
hdfc life insurance compa... 1.38 1.37 1.23 1.14 -
investor education and pr... - 0.27 0.27 0.27 -
mirae asset large & midca... 3.03 3.04 2.98 - -
aditya birla sun life tru... 2.27 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Bayer CropScience informs about disclosure 31 Jan, 4:52 PM Bayer Cropscience informs about board meeting 21 Jan, 2:48 PM Bayer CropScience informs about change in name of RTA 1 Jan, 5:15 PM Bayer CropScience informs about closure of trading window 18 Dec, 4:45 PM Bayer Cropscience informs about details of loss of certificate 13 Dec, 4:57 PM Bayer CropScience - Quaterly Results 13 Nov, 5:21 PM Bayer CropScience - Quaterly Results 13 Nov, 5:21 PM Bayer CropScience - Quaterly Results 13 Nov, 5:21 PM Bayer CropScience informs about loss of share certificates 16 Oct, 3:53 PM Bayer CropScience informs about disclosure 11 Oct, 11:15 AM Bayer CropScience informs about presentation 14 Aug, 5:01 PM Bayer CropScience - Quaterly Results 8 Aug, 5:29 PM Bayer CropScience - Quaterly Results 8 Aug, 5:29 PM Bayer CropScience - Quaterly Results 8 Aug, 5:29 PM Bayer Cropscience informs about annual report 17 Jul, 12:33 PM Bayer Cropscience informs about disclosure 21 Jun, 12:20 PM Bayer Cropscience informs about disclosure 20 Jun, 4:14 PM Bayer CropScience informs about issuance of duplicate share certificate 6 Jun, 3:46 PM Bayer Cropscience informs about newspaper publication 25 May, 11:42 AM Bayer CropScience - Quaterly Results 23 May, 7:13 PM Bayer CropScience - Quaterly Results 23 May, 7:13 PM Bayer CropScience submits newspaper publication for outcome of postal Ballot 27 Mar, 12:56 PM Bayer CropScience informs about newspaper advertisement 24 Feb, 12:52 PM Bayer CropScience informs about newspaper advertisement 3 Feb, 2:58 PM Bayer CropScience - Quaterly Results 1 Feb, 5:51 PM Bayer CropScience - Quaterly Results 1 Feb, 5:51 PM Bayer CropScience - Quaterly Results 1 Feb, 5:51 PM Bayer Cropscience informs about issuance of duplicate share certificate 25 Jan, 5:28 PM Bayer CropScience informs about loss of share certificates 2 Jan, 12:41 PM Bayer CropScience informs about newspaper advertisement 21 Dec, 2:07 PM Bayer Cropscience informs about newspaper advertisement 1 Dec, 12:17 PM Bayer CropScience informs about newspaper advertisement 4 Nov, 2:56 PM Bayer Cropscience informs about press release 3 Nov, 3:18 PM Bayer Cropscience informs about outcome of board meeting 3 Nov, 3:11 PM Bayer CropScience - Quaterly Results 3 Nov, 12:51 PM Bayer CropScience - Quaterly Results 3 Nov, 12:51 PM Bayer CropScience - Quaterly Results 3 Nov, 12:51 PM Bayer Cropscience informs about loss of share certificates 31 Oct, 3:26 PM Bayer Cropscience informs about compliance certificate 5 Oct, 5:21 PM Bayer Cropscience informs about details of loss of certificate 20 Sep, 1:20 PM Bayer Cropscience informs about loss of share certificate 1 Sep, 3:44 PM Bayer CropScience - Quaterly Results 7 Aug, 4:49 PM Bayer CropScience - Quaterly Results 7 Aug, 4:49 PM Bayer CropScience - Quaterly Results 7 Aug, 4:49 PM Bayer CropScience informs about issuance of duplicate share certificate 4 Aug, 4:48 PM Bayer CropScience informs about newspaper advertisement 13 Jul, 3:10 PM Bayer Cropscience informs about newspaper publication 5 Jul, 1:11 PM Bayer CropScience informs about 65th AGM 4 Jul, 4:24 PM Bayer CropScience informs about record date and book closure 4 Jul, 4:18 PM Bayer CropScience informs about loss of share certificates 3 Jul, 5:21 PM

Bayer CropScience Stock Price Analysis and Quick Research Report. Is Bayer CropScience an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Bayer CropScience stock price today is Rs 5055.5. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Bayer CropScience . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Bayer CropScience has a PE ratio of 39.2002543305988 which is high and comparatively overvalued .

  • Share Price: - The current share price of Bayer CropScience is Rs 5055.5. One can use valuation calculators of ticker to know if Bayer CropScience share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Bayer CropScience has ROA of 9.7976 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Bayer CropScience has a Current ratio of 2.2717 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Bayer CropScience has a ROE of 26.6295 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Bayer CropScience has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Bayer CropScience has reported revenue growth of -0.7102 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Bayer CropScience for the current financial year is 18.6314469352563 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Bayer CropScience is Rs 140 and the yield is 2.763 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Bayer CropScience is Rs 128.966 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Bayer CropScience in Ticker for free. Also, one can get the intrinsic value of Bayer CropScience by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Bayer CropScience

Bayer CropScience Ltd. Financials: Check Share Price, Balance Sheet, Annual Report and Quarterly Results for Company Analysis

 

Bayer CropScience Ltd. is a leading global player in the field of crop protection and seeds. As a long-term stock investor, it is important to analyze the company's financial health and performance to make informed investment decisions.  We will analyze Bayer CropScience Ltd.'s stock using various parameters such as share price, balance sheet, annual report, dividend, quarterly result, stock price, price chart, news, concall, transcripts, investor presentations, promoters, and shareholders.

Bayer CropScience Ltd Share Price

Stay informed about the latest trends in the stock market as we analyze the share price of Bayer CropScience Ltd. Our aim is to equip long-term stock investors with the necessary information to make informed investment decisions.

Bayer CropScience Ltd Balance Sheet

Bayer CropScience Ltd.'s balance sheet shows a strong financial position. The company has a healthy asset base and a low debt-to-equity ratio. Ticker pre-built screening tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis can be used to calculate the fair value of the stock.

Bayer CropScience Ltd Annual Report

Bayer CropScience Ltd.'s annual report provides a detailed overview of the company's financial performance, business strategy, and future plans. The annual report is available for download on Ticker. Investors can use the information in the annual report to make informed investment decisions.

Bayer CropScience Ltd Dividend

Bayer CropScience Ltd. has a consistent dividend payout history. The company has been paying dividends regularly for the past few years. However, it is important to note that the dividend payout can be affected by various factors such as the company's financial performance, future plans, and market conditions.

Bayer CropScience Ltd Quarterly Result

Bayer CropScience Ltd.'s quarterly results provide a snapshot of the company's financial performance in the short term. Ticker pre-built screening tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis can be used to analyze the quarterly results.

Bayer CropScience Ltd Stock Price

Bayer CropScience Ltd.'s stock price can be affected by various factors such as the company's financial performance, market conditions, and investor sentiment. It is important to focus on long-term trends and use pre-built screening tools to analyze the stock price.

Bayer CropScience Ltd Price Chart

Bayer CropScience Ltd.'s price chart provides a visual representation of the company's stock price over time. The price chart can be used to identify long-term trends and patterns in the stock price.

Bayer CropScience Ltd News

Bayer CropScience Ltd.'s news section provides the latest updates about the company's financial performance, business strategy, and future plans. Investors can use the news section to stay updated about the company's developments.

Bayer CropScience Ltd Concall

Bayer CropScience Ltd.'s concall provides an opportunity for investors to interact with the company's management and ask questions about the company's financial performance, business strategy, and future plans. Investors can use the concall to get a better understanding of the company's operations.

Bayer CropScience Ltd Transcripts

Bayer CropScience Ltd.'s transcripts provide a detailed record of the company's concall. The transcripts can be used to analyze the company's responses to investors' questions and get a better understanding of the company's operations.

Bayer CropScience Ltd Investor Presentations

Bayer CropScience Ltd.'s investor presentations provide a detailed overview of the company's financial performance, business strategy, and future plans. The investor presentations can be used to make informed investment decisions.

Bayer CropScience Ltd Promoters

Bayer CropScience Ltd.'s promoters are the individuals or entities that hold a significant stake in the company. The promoters play a key role in the company's decision-making process and can influence the company's operations.

Bayer CropScience Ltd Shareholders

Bayer CropScience Ltd.'s shareholders are the individuals or entities that hold a stake in the company. The shareholders can influence the company's decision-making process through voting rights and can benefit from the company's financial performance through dividends and capital appreciation.

Bayer CropScience Ltd ROCE

Bayer CropScience Ltd ROCE (Return on Capital Employed) is a financial ratio that measures the company's profitability in relation to its capital investments. By analyzing the ROCE data for Bayer CropScience Ltd available on this page, investors can assess the company's capital efficiency and profitability. The ROCE indicates how efficiently the company is utilizing its capital to generate profits. Detailed ROCE data can be found in the financials table or ratio section provided above.

Bayer CropScience Ltd EBITDA

Bayer CropScience Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is a key metric that helps understand the company's operational profitability. By excluding non-operating expenses, EBITDA provides insights into the core business performance of Bayer CropScience Ltd. Investors can access the EBITDA data for the company in the financials table or ratio section above. EBITDA is a valuable indicator of the company's operating performance.

Bayer CropScience Ltd DPS

Bayer CropScience Ltd DPS (Dividends Per Share) represents the cash distributed to shareholders for each share held in the company. Understanding the DPS data helps investors assess the company's dividend policy and potential returns. The DPS is an important metric for income-focused investors seeking regular payouts. Detailed DPS information for Bayer CropScience Ltd can be found in the financials table or ratio section provided above.

Bayer CropScience Ltd EPS

Bayer CropScience Ltd EPS (Earnings Per Share) is a crucial metric that indicates the company's profitability on a per-share basis. By analyzing the EPS data, investors can evaluate the company's earning potential and performance. EPS is a fundamental measure used to assess the value and growth potential of Bayer CropScience Ltd's stock. Access the detailed EPS data for the company in the financials table or ratio section available above. 

Bayer CropScience Balance Sheet Analysis

Bayer CropScience Equity and Liabilities

The Bayer CropScience Balance Sheet showcases a consistent increase in Total Liabilities from Rs 5,927.80 Cr in March 2020 to Rs 7,616.30 Cr by March 2024. Notably, Share Capital remains stable at Rs 44.90 Cr throughout the period, indicating no new equity issuance. The Total Reserves saw a gradual rise from Rs 2,527.60 Cr in 2020 to Rs 2,804.50 Cr in 2024, suggesting a strengthening financial reserve.

Bayer CropScience Debt Analysis

Interestingly, Bayer CropScience maintained zero borrowings across the five years, highlighting a debt-free status that is admirable in today’s corporate environment. This positions the company uniquely in terms of financial stability and risk management.

Bayer CropScience Assets Overview

On the assets front, Bayer CropScience's Total Assets have grown parallel to liabilities, from Rs 5,927.80 Cr in March 2020 to Rs 7,616.30 Cr by March 2024. The most significant growth has been in Loans & Advances, increasing from Rs 1,762.90 Cr to Rs 2,959.70 Cr, which indicates aggressive investment in driving the company’s growth. However, there's a noticeable decrease in Net Block from Rs 438 Cr to Rs 389.40 Cr, reflecting asset depreciation or possible asset disposals.

Additional Insights

One key observation is the company’s strategic investment in intangible assets, notably rising from Rs 52.30 Cr in 2020 to Rs 112.20 Cr in 2024, demonstrating Bayer CropScience's focus on intellectual property and possibly, research and development initiatives.

This analysis is based on the Standalone Balance Sheet of Bayer CropScience.

Investors analyzing this company may also engage in stock screening across various sectors on platforms to compare with other entities in the NSE and BSE indices.

Read More
X